Table 2.
Amount of protein present in commercial preparations of common lipases
| Commercial lipase preparation | Supplier | Protein content (%) | Method of measurement | Reference |
|---|---|---|---|---|
| CRL (VII ) |
Sigma Chemicals Co. (Missouri, USA) |
22 |
n.a. |
Arroyo (1995) |
| CRL (VII) |
Sigma Chemicals Co. (St. Louis, USA). |
6 |
Lowry |
López et al. (2004) |
| CRL (VII) |
Sigma Chemicals Co. (St. Louis, USA). |
9.3 |
n.a. |
Gitlesen et al. (1997) |
| CRL (AY 30) |
Amano (Nagoya, Japan) |
3.3 |
Lowry |
López et al. (2004) |
| CRL (AY) |
Amano (Nagoya, Japan) |
10 |
n.a. |
Gitlesen et al. (1997) |
| CRL (AY) |
Amano (Nagoya, Japan) |
1.1 |
Bradford |
Salis et al. (2008) |
| PS (Lipase PS) |
Amano (Nagoya, Japan) |
0,55 |
Bradford |
Salis et al. (2008) |
| PS (Chirazyme L-9, Lyo) |
Roche Diagnostics (Germany) |
12 |
Micro-Bradford (Standard:BSA) |
Guieysse et al. (2004) |
| PFL (Lipase AY) |
Amano (Nagoya, Japan) |
2 |
Bradford |
Salis et al. (2008) |
| RML (Chirazyme L-9, Lyo) |
Roche Diagnostics (Germany) |
15 |
Micro-Bradford (Standard:BSA) |
Guieysse et al. (2004) |
| CALB Novozym 435 |
Novozymes A/S (Bagsvaerd Denmark) |
8 |
Precipitation with acetone |
Prabhavathi et al. (2009) |
| CALB SP525 |
Novo Nordisk Biondustrias, S.A. (Madrid, España) |
10 |
Biuret |
López et al. (2004) |
| Lipozyme CALB (Optimized value) |
Novozymes |
30 |
Precipitation with (NH4)2SO4 |
This work |
| Lipozyme TLL (Optimized value) | Novozymes | 20 | Precipitation with (NH4)2SO4 | This work |